We're crowdfunding! Own a part of our business. Capital at Risk.
View our pitch

Johnny Sutton joins the Stablepharma Ltd Board of Directors

We are delighted to announce that Johnny Sutton, founder and CEO of Oval Investments, will become a member of the Board of Stablepharma Ltd. Johnny joins the Board of the ‘Fridge-free Vaccine Company’, following Oval Investments’ major participation in the Series A fundraise, recently completed on 31st October 2022. https://stablepharma.com/team/johnny-sutton/

With extensive experience within Investment Banking, including Wood Mackenzie & Co, UBS and Dresdner Kleinwort Wasserstein, Johnny brings a wealth of investment experience at board level and significant relationships with VC funds, Family Offices and HNWs.

“Johnny is a great addition to the Board of Stablepharma, with his cross-sector investment experience and global perspectives on growth financing”, said Özgür Tuncer, CEO & Executive Director of Stablepharma Ltd.

Johnny founded Oval Investments in the spring of 2011 and focuses on raising growth capital for unlisted companies.

‘Oval Investments is excited to be an investor in such an innovative biotech company. The Stablepharma team are clearly focussed on their vision to make fridge-free vaccines a reality, reduce waste and save lives. This vision was a big incentive for us to invest and we believe that fridge-free vaccines will have an enormous impact on the world”, added Johnny.

“Adding experience to our Board is just another step forward in achieving our vision’, added Özgür. ‘In just a short period of time, and following our recent partnership agreements, we have transformed from a technology company to a product development Biotech and I am very excited about the future” Stablepharma and Bul Bio sign agreement on Tetanus diphtheria vaccine (manufacturingchemist.com)